Cyient Limited issues notice on Buyback of its Equity Shares
The Company's public announcement relating to the Buyback ("PA") was published on
If you have any questions regarding an Equity Share withdrawal or the Buyback, please call the Company at +91 40 6764 1322 or send an e-mail to [email protected].
All dates set out herein are as observed in
Statement Regarding Buyback
The anticipated Buyback discussed in this press release has not yet commenced. This press release is provided for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to purchase any securities of the Company pursuant to Company's Buyback or otherwise. Any offer to purchase or solicitation of offer to sell will be made pursuant to a letter of offer and other documents relating to the Buyback. The Company's security holders are advised to carefully read these documents, any amendments to these documents and any other documents relating to the buyback in their entirety prior to making any decision with respect to the Company's Buyback because these documents contain important information, including the terms and conditions of the Buyback.
Related link
https://www.cyient.com/investors/financial-information
Media Contact: +91 40 6764 1322 | [email protected]
Logo: https://mma.prnewswire.com/media/2996870/Cyient_Limited_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/cyient-limited-issues-notice-on-buyback-of-its-equity-shares-302798964.html
SOURCE Cyient Limited
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
- Best Gold IRA Companies With Low Fees in 2026 (Rankings Released)
- Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share